Transport networks and inequities in vaccination: Remoteness shapes measles vaccine coverage and prospects for elimination across Africa

Epidemiology and Infection

Volumn 143, Issue 7, 2015, Pages 1457-1466

  Metcalf, C J E ^a,b,c   Tatem, A ^b,d,e   Bjornstad, O N ^f   Lessler, J ^g   O'Reilly, K ^h   Takahashi, S ^c   Cutts, F ⁱ   Grenfell, B T ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c PRINCETON UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e FLOWMINDER FOUNDATION   (Sweden)

^f PENNSYLVANIA STATE UNIVERSITY   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Epidemiology; measles (rubeola); modelling; rubella; vaccine policy development

Indexed keywords

MEASLES VACCINE;

AFRICA; AGE DISTRIBUTION; ARTICLE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HUMAN; MEASLES VACCINATION; NONHUMAN; POPULATION DISTRIBUTION; RURAL AREA; WORLD HEALTH ORGANIZATION; AGE; DISEASE ERADICATION; GEOGRAPHY; HERD IMMUNITY; IMMUNOLOGY; INFANT; MEASLES; PRESCHOOL CHILD; RUBELLA; SOCIOECONOMICS; STANDARDS; STATISTICS AND NUMERICAL DATA; TRAFFIC AND TRANSPORT; VACCINATION;

AFRICA; AGE FACTORS; CHILD, PRESCHOOL; DISEASE ERADICATION; GEOGRAPHY; HUMANS; IMMUNITY, HERD; INFANT; MEASLES; MEASLES VACCINE; RUBELLA; SOCIOECONOMIC FACTORS; TRANSPORTATION; VACCINATION;

EID: 84926419845     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814001988     Document Type: Article

References (47)

1. Centers for Disease Control and Prevention. Vaccine preventable deaths and the Global Immunization Strategy 2006-2015. Morbidity and Mortality Weekly Report 2006; 55: 511-515.
2. Strebel P, et al. The unfinished measles immunization agenda. Journal of Infectious Diseases 2003; 187: S1-S7.
3. World Health Organization. Global control and regional elimination of measles, 2000-2012. Weekly Epidemiological Record 2014; 89: 45-52.
4. Lee LA, et al. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance. Vaccine 2013; 31: B61-B72.
5. Strebel PM, et al. A world without measles. Journal of Infectious Diseases 2011; 204 (Suppl. 1): S1-S3.
6. Sartorius B, et al. Identifying high-risk areas for sporadic measles outbreaks: lessons from South Africa. Bulletin of the World Health Organization 2013; 91: 174-183.
7. Cutts F, Lessler J, Metcalf CJE. Measles elimination: progress, challenges and implications for rubella control. Expert Review of Vaccines 2013; 12: 917-932.
8. World Health Organization. Global measles and rubella strategic plan, 2012-2020. WHO, 2012.
9. Machingaidze S, Wiysonge CS, Hussey GD. Strengthening the expanded programme on immunization in Africa: looking beyond 2015. PLoS Medicine 2013; 10: e1001405.
10. Blanford JI, et al. It's a long, long walk: accessibility to hospitals, maternity and integrated health centers in Niger. International Journal of Health Geographics 2012; 11: 1-15.
11. Victora CG, et al. How changes in coverage affect equity in maternal and child health interventions in 35 countdown to 2015 countries: an analysis of national surveys. Lancet 2012; 380: 1149-1156.
12. Rheingans R, Atherly D, Anderson J. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Vaccine 2012; 30: A15-A23.
13. Zuber PLF, et al. Mass measles vaccination in urban Burkina Faso, 1998. Bulletin of the World Health Organization 2001; 79: 4.
14. Cockcroft A, et al. One size does not fit all: local determinants of measles vaccination in four districts of Pakistan. BMC International Health and Human Rights 2009; 9 (Suppl. 1): S4.
15. Mitchell V, et al. Immunization in developing countries. In Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Philadelphia: Elsevier Saunders, 2013, pp. 1369-1394.
16. Berry DJ, Yach D, Hennink MHJ. An evaluation of the national measles vaccination campaign in the new shanty areas of Khayelitsha. South African Medical Journal 1992; 79: 433-436.
17. Grais RF, et al. Unacceptably high mortality related to measles epidemics in Niger, Nigeria and Chad. PLoS Medicine 2007; 4: e16.
18. Schelling E, et al. Human and animal vaccination delivery to remote nomadic families, Chad. Emerging Infectious Diseases 2007; 13: 373-379.
19. Fernandez R, et al. Determinants of apparent rural-urban differentials in measles vaccination uptake in Indonesia. Rural and Remote Health 2011; 11(1702).
20. Singh PK, Trends in child immunization across geographical regions in India: focus on urban-rural and gender differentials. PLoS One 2013; 8: e73102.
21. Weldegebriel GG, et al. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008. Journal of Infectious Diseases 2011; 204 (Suppl. 1): S226-S231.
22. Moïsi JC, et al. Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable? Vaccine 2010; 28: 5725-5730.
23. Wallinga J, Heijne JCM, Kretzschmar M. A measles epidemic threshold in a highly vaccinated population. PLoS Medicine 2005; 2: e316.
24. Strebel PM, et al. Global use of rubella vaccines, 1980-2009. Journal of Infectious Diseases 2011; 204: S579-584.
25. Cutts F, et al. Rubella vaccination: must not be business as usual. Lancet 2012; 380: 217-218.
26. World Health Organization. Rubella vaccines: WHO position paper. Weekly Epidemiological Record 2011; 86: 301-316.
27. Metcalf CJE, et al. Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa. Journal of the Royal Society Interface 2013; 10: 20120756.
28. Bartlett MS, The critical community size for measles in the United States. Journal of the Royal Statistical Society, Series A 1960; 123: 37-44.
29. Cooper LZ, The history and medical consequences of rubella. Reviews of Infectious Diseases 1985; 7: S2-S10.
30. Orenstein WA, Papania MJ, Wharton ME. Measles elimination in the United States. Journal of Infectious Diseases 2004; 189 (Suppl. 1): S1-S3.
31. Metcalf CJE, et al. Minimum levels of coverage needed for rubella vaccination: impact of local demography, seasonality and population heterogeneity. Epidemiology and Infection 2012; 16: 1-12.
32. Lessler J, Metcalf CJE. Balancing evidence and uncertainty when considering rubella vaccine introduction. PLoS One 2013; 8: e67639.
33. ICF International. Demographic and Health Surveys (various) [Benin 2001: BJKR41FL.dta, BJGE42FL.dbf; Burkina Faso 2003 BFKR42FL.dta, BFGE43FL.dbf; Burkina Faso 2010: BFKR61FL.dta, BFGE61FL.dbf; Burundi 2010: BUKR61FL.dta, BUGE61FL.dbf; Cameroon 2004: CMKR44FL.dta, CMGE42FL.dbf; Cameroon 2011: CMKR60FL.dta, CMGE61FL.dbf; Congo (DRC 2007: CDKR50FL. dta, CDGE52FL.dbf; Egypt 2000: EGKR41FL.dta, EGGE42FL.dbf; Egypt 2005: EGKR51FL.dta, EGGE52FL.dbf; Egypt 2008: EGKR5AFL.dta, EGGE5DFL.dbf; Ethiopia 2000: ETKR41FL.dta, ETGE42FL.dbf; Ethiopia 2005: ETKR51FL.dta, ETGE52FL.dbf; Ethiopia 2011: ETKR61LF.dta, ETGE61FL.dbf; Ghana 2003: GHKR4BFL.dta, GHGE4BFL.dbf; Ghana 2008: GHKR5AFL.dta, GHGE5AFL.dbf; Guinea 2005: GNKR52FL.dta, GNGE52FL.dbf; Kenya 2003: KEKR42FL.dta, KEGE43FL.dbf; Kenya 2008-2009: KEKR52Fl.dta, KEGE52FL.dbf; Lesotho 2004; LSKR41FL.dta, LSGE42FL.dbf; Lesotho 2009: LSKR60FL.dta, LSGE62FL.dbf; Liberia 2007: LBKR51FL.dta, LBGE52FL.dbf, Madagascar 2008-2009: MDKR51FL.dta, MDGE53FL.dbf; Malawi 2000: MWKR41FL.dta, MWGE43FL.dbf; Malawi 2004: MWKR4CFl.dta, MWGE4BFL.dbf; Malawi 2010: MWKR4CFL.dta, MWGE4BFL.dbf; Mali 2001: MLKR41FL.dta, MLGE42FL.dbf; Mali 2006: MLKR52FL.dta, MLGE42FL.dbf; Morocco 2003: MAKR42FL.dta, MAGE43FL.dbf; Namibia 2000: NMKR41FL.dta, NMGE42FL.dbf; Namibia 2006: NMKR51FL.dta, NMGE52FL.dbf; Nigeria 2003: NGKR4BFL.dta, NGGE4BFL.dbf; Nigeria 2008: NGKR51FL.dta, NGGE52FL.dbf; Rwanda 2005: RWKR53FL.dta, RWGE54FL.dbf; Rwanda 2010: RWKR61FL.dta, RWGE61FL.dbf; Senegal 2005: SNKR4HFL.dta, SNGE4BFL.dbf; Senegal 2010: SNKR60FL.dta, SNGE61FL.dbf; Sierra Leone 2008: SLKR51FL.dta, SLGE53FL.dbf; Swaziland 2006: SZKR51FL.dta, SZGE53FL.dbf; Tanzania 1999: TZKR41FL.dta, TZGE43FL.dbf; Tanzania 2010: TZKR60FL.dta, TZGE61FL.dbf; Uganda 2000-2001: UGKR41FL.dta, UGGE43FL.dbf; Uganda 2006: UGKR51FL.dta, UGGE52FL.dbf; Uganda 2011: UGKR60FL.dta, UGGE61FL.dbf; Zambia 2007L ZNKR51FL.dta, ZMGE52FL.dbf; Zimbabwe 2005-2006: ZWKR51FL.dta, ZWGE52FL.dbf], 2012. Calverton, Maryland: ICF International.
34. ICF Macro. Incorporating geographic information into demographic and health surveys: a field guide to GPS data collection. ICF Macro: Calverton, Maryland, USA, 2011.
35. Arino O, et al. GLOBCOVER: the most detailed portrait of Earth. ESA Bulletin 2008; 136: 24-31.
36. Linard C, et al. Population distribution, settlement patterns and accessibility across Africa in 2010. PLoS One 2012; 7: e31743.
37. Lehner B, Doll P. Development and validation of a global database of lakes, reservoirs and wetlands. Journal of Hydrology 2004; 296: 1-22.
38. Rabus B, et al. The shuttle radar topography mission-a new class of digitial elevation models acquired by spaceborne radar. Photogrammetric Engineering & Remote Sensing 2003; 27: 241-262.
39. Nelson A. Estimated travel time to the nearest city of 50,000 or more people in year 2000. Ispra, Italy, 2008 (http://bioval.jrc.ec.europa.eu/products/gam/index.htm). Accessed 11 October 2011.
40. Loader C. Local Regression and Likelihood. New York: Springer, 1999.
41. Härdle W. Applied Nonparametric Regression. Cambridge: Cambridge University Press, 1990.
42. World Health Organization. Global vaccine action plan 2011-2020. WHO, 2013.
43. Lessler J, et al. Measuring the performance of vaccination programs using cross-sectional surveys. PLoS Medicine 2011; 8: e1001110.
44. Anderson RM, May RM. Infectious Diseases of Humans. Oxford: Oxford University Press, 1991.
45. Bharti N, et al. Explaining seasonal fluctuations of measles in Niger using nighttime lights imagery. Science 2011; 334: 1424-1427.
46. Klepac P, et al. Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 2013; 368 (1623): 20120137.
47. Metcalf CJE, et al. Rubella meta-population dynamics and importance of spatial coupling to the risk of congenital rubella syndrome in Peru. Journal of the Royal Society Interface 2011; 8: 369-376.